Notizie e Aggiornamenti su Bluejay
Torna al ProfiloRicevi le ultime notizie, aggiornamenti e contenuti su Bluejay. Non perderti pettegolezzi o nuovi contenuti per adulti.
Bluejay Electric Bikes Unveils New Limited-Edition 2027 Models, With Only 180 Bikes Available
Bluejay Electric Bikes, the premium e-bike brand, known for its vintage-inspired and luxurious desig...
Bluejay’s ‘Lite’ E-Bike Is A Stylish Ride And Sportier Than Expected
Forbes contributors publish independent expert analyses and insights. William covers motorbikes, E-b...
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
The partnership provides Bluejay with a strategic framework to access and pursue opportunities acros...
This Electric Bike Replaced My Car and Reduced My Carbon Footprint
While each product featured is independently selected by our editors, we may include paid promotion....
Bluejay Diagnostics federal healthcare partnership builds commercial pathway ahead of FDA clearance
The Lovell Government Services agreement establishes federal procurement infrastructure for the Symp...
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" ...
Bluejay Sport Review: A Vintage-Looking Ebike For City And Off-Road Adventures
Founded by Jen Cohen Bogan, Bluejay Bikes is a female-owned electric bike brand which made a bit of ...
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical ...
Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care
This Study performs unique rapid on-site measurement using patient whole blood and positions Company...
Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Bluejay Therapeutics, a clinical-stage biopharmaceutical company...
BlueJay is a music playing, editing, and recording software for Windows
Audio players have come a long way, and these days, many of them are not just about playing tunes an...
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances towar...
Bluejay stock holds value as critical minerals theme strengthens
Within that environment, Bluejay stock sits in a niche between early-stage exploration and potential...
Bluejay Mining goes solo at Finland project as JV with Rio Tinto ends
Bluejay Mining (LON: JAY) said Monday that it will take full ownership of the Enonkoski nickel-coppe...
Bluejay Capital’s Pacific West Acquires Coleman Industrial Construction in Midwest
Founded in 1979, Coleman Industrial Construction provides construction, renovation, environmental, m...
Pacific West Environmental & Infrastructure Acquires Coleman Industrial Construction, Extending Rail Services Platform into the Midwest
Pacific West, a premier rail and industrial infrastructure services company backed by Bluejay Capita...
Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
Bluejay's first product candidate, an IL-6 Test for sepsis triage, is designed to provide accurate, ...
Bluejay Diagnostics, Lovell Team Up To Access U.S. Federal Healthcare Market
Bluejay's Symphony System is an investigational rapid diagnostic platform designed for Its first pro...
5 Biotech Stocks To Watch: Bluejay, Pharvaris, Roivant, PDSB & Atara
Atara Biotherapeutics ( ATRA) provided an update on the anticipated resubmission of the BLA for Tabe...
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the ...
REDWOOD CITY, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biop...
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
Company focused on advancing clinical milestones and strategic partnerships, with goal of positionin...
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds u...
Mirum beckons Bluejay and its phase 3-stage hepatitis drug for $620M
Mirum Pharmaceuticals is paying $620 million in cash and stock to buy Bluejay Therapeutics and its p...
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update
ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" ...
Inside The Growing Popularity of Bluejay e-bikes
The popularity of electric bikes is unmistakable, but Jennifer Cohen Bogan saw a gap in the market f...
Why Are Traders Watching Bluejay Diagnostics (NASDAQ:BJDX) This Week?
Bluejay Diagnostics (NASDAQ:BJDX) shares climbed after completing enrollment ahead of schedule in it...
Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results
Bluejay's Symphony System (the "Symphony System") is designed to address the need for simple, reliab...
Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and ...
SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances towar...
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay"...
Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal'
・Brelovitug is a late-stage experimental drug being studied for chronic hepatitis delta virus infe...